I wasn't going to post this question on the public
Post# of 148190
(Total Views: 550)
Posted On: 02/01/2023 8:43:14 PM
I wasn't going to post this question on the public board until I thought it through a little more, but Jake's analysis is always well thought through and well sought after, so, here goes:
You state:
If you are correct, does that now make the bond an asset, rather than a liability?
If CytoDyn actually paid off the bond, as you and I are apparently reading between the lines might have happened, and assuming that the bond is never called, after bond premiums, won't the money eventually go back to CytoDyn? Again, assuming that it was actually paid off and assuming that CytoDyn is never required to use the bond to pay Amarex.
You state:
Quote:
With that in mind, it would appear to me that CYDY has satisfied the promissory note issued to David Welch (CYDY's largest shareholder) and secured by the Leronlimab patent, in return for Mr Welch having guaranteeing the 6.5 million dollar bond posted by CYDY as a condition of the arbitration proceeding moving forward.
If you are correct, does that now make the bond an asset, rather than a liability?
If CytoDyn actually paid off the bond, as you and I are apparently reading between the lines might have happened, and assuming that the bond is never called, after bond premiums, won't the money eventually go back to CytoDyn? Again, assuming that it was actually paid off and assuming that CytoDyn is never required to use the bond to pay Amarex.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼